Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models

Microbes and Infection

Volumn 12, Issue 1, 2010, Pages 11-18

  Hong, Wenzhou ^a   Peng, Daxin ^a   Rivera, Maritza ^a   Gu, Xin Xing ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Chinchilla models; Lipooligosaccharide conjugate vaccine; Mucosal immunization; Nontypeable Haemophilus influenzae

Indexed keywords

CHOLERA TOXIN; HAEMOPHILUS INFLUENZAE VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPOOLIGOSACCHARIDE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIOPHAGE TYPING; BACTERIUM CULTURE; CHINCHILLA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG CONJUGATION; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; MUCOSAL IMMUNITY; NASOPHARYNX; NONHUMAN; NOSE MUCOSA; NOSE MUCUS; OTITIS MEDIA; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; CARRIER STATE; CHINCHILLA; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; LIPOPOLYSACCHARIDES; NASOPHARYNX; OTITIS MEDIA; TETANUS TOXOID; VACCINES, CONJUGATE;

ANIMALIA; BACTERIA (MICROORGANISMS); CHINCHILLIDAE; HAEMOPHILUS INFLUENZAE;

EID: 72949104556     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.09.006     Document Type: Article

References (30)

1. Bondy J., Berman S., Glazner J., and Lezotte D. Direct expenditures related to otitis media diagnosis: extrapolations from a pediatric medicaid cohort. Pediatrics 105 (2000) e72
2. Benninger M. Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine. Otolaryngol. Head Neck. Surg. 138 (2008) 274-278
3. Casey J., and Pichichero M. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr. Infect. Dis. J. 23 (2004) 824-828
4. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., Kohl I., Lommel P., Poolman J., Prieels J., and Schuerman L. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 (2006) 740-748
5. Hanage W., Huang S., Lipsitch M., Bishop C., Godoy D., Pelton S., Goldstein R., Huot H., and Finkelstein J. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 195 (2007) 347-352
6. Cripps A., and Otczyk D. Prospects for a vaccine against otitis media. Expert Rev. Vaccine 5 (2006) 517-534
7. DeMaria T., Murwin D., and Leake E. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Infect. Immun. 64 (1996) 5187-5192
8. Gu X.-X., Sun J., Jin S., Barenkamp S., Lim D., Robbins J., and Battey J. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas. Infect. Immun. 65 (1997) 4488-4493
9. Loosmore S., Yang Y., Oomen R., Shortreed J., Coleman D., and Klein M. The Haemophilus influenzae HtrA protein is a protective antigen. Infect. Immun. 66 (1998) 899-906
10. Sirakova T., Kolattukudy P., Murwin D., Billy J., Leake E., Lim D., DeMaria T., and Bakaletz L. The role of fimbriae expressed by nontypable Haemophilus influenzae (NTHi) in the pathogenesis of and protection against otitis media and the relatedness of the fimbrin subunit to outer membrane protein A. Infect Immun. 62 (1994) 2002-2020
11. McGhee J., Mestecky J., Dertzbaugh M., Eldridge J., Hirasawa M., and Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10 (1992) 75-88
12. Novotny L., Jurcisek J., Godfroid F., Poolman J., Denoel P., and Bakaletz L. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae. Vaccine 24 (2006) 4804-4811
13. Harabuchi Y., Faden H., Yamanaka N., Duffy L., Wolf J., and Krystofik D. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville pediatrics. J. Infect. Dis. 170 (1994) 862-866
14. Kurono Y., Fujiyoshi T., and Mogi G. Secretory IgA and bacterial adherence to nasal mucosal cells. Ann. Otol. Rhinol. Laryngol. 98 (1989) 273-277
15. Bertot G., Becker P., Guzmán C., and Grinstein S. Intranasal vaccination with recombinant P6 Protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung Infection by nontypeable Haemophilus influenzae. J. Infect. Dis. 189 (2004) 1304-1312
16. Hirano T., Hou Y., Jiao X., and Gu X.-M. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. FEMS Immunol. Med. Microbiol. 35 (2003) 1-10
17. Mason K., Zhu D., Scheuer C., McMichael J., Zlotnick G., and Green B. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine 22 (2004) 3449-3456
18. Sabirov A., Kodama S., Hirano T., Suzuki M., and Mogi G. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect. Immun. 69 (2001) 2964-2971
19. Giebink G. Otitis media: the chinchilla model. Microb. Drug. Resist. 5 (1999) 57-72
20. Kyd J., Cripps A., Novotny L., and Bakaletz L. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Infect. Immun. 71 (2003) 4691-4699
21. Suzuki K., and Bakaletz L. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect. Immun. 62 (1994) 1710-1718
22. Yang Y., Loosmore S., Underdown B., and Klein M. Nasopharyngeal colonization with nontypeable Haemophilus influenzae in chinchillas. Infect. Immun. 66 (1998) 1973-1980
23. Gu X.-X., Tsai C.-M., Ueyama T., Barenkamp S., Robbins J., and Lim D. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect. Immun. 64 (1996) 4047-4053
24. Gu X.-X., Rudy S., Chu C., McCullagh L., Kim H., Chen J., Li J., Robbins J., Van Waes C., and Battey J. Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae. Vaccine 21 (2003) 2107-2114
25. Boettcher F., Bancroft B., and Salvi R. Blood collection from the transverse sinus in the chinchilla. Lab. Anim. Sci. 40 (1990) 223-224
26. Tong H., Blue L., James M., and DeMaria T. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect. Immun. 68 (2000) 921-924
27. Giebink G., Heller K., and Le C. Prediction of serous versus purulent otitis media by otoscopy and tympanometry in an animal model. Laryngoscope 93 (1983) 208-211
28. Barenkamp S. Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media. Infect. Immun. 52 (1986) 572-578
29. Robbins J., Schneerson R., and Szu S. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171 (1995) 1387-1398
30. Sun J., Chen J., Cheng Z., Robbins J., Battey J., and Gu X.-X. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model. Vaccine 18 (2000) 1264-1272